Moderna (MRNA) capital expenditure was $202M in FY2025 (-81% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2025
$202M
-81%
2024
$1.1B
+49%
2023
$707M
+77%
2022
$400M
+41%
2021
$284M
+318%
2020
$68M
+112%
2019
$32M
-70%
2018
$106M
+81%
2017
$58M
+76%
2016
$33M
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q2 2026
$37M
Q1 2026
$62M
Q4 2025
$39M
Q3 2025
$33M
Q2 2025
$3M
Q1 2025
$127M
Q4 2024
$522M
Q3 2024
$151M
Q2 2024
$182M
Q1 2024
$196M
Q4 2023
$220M
Q3 2023
$140M
Source: MRNA on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.